Erythroferrone may function as negative regulator of bone remodeling in beta-thalassemia
ORLANDO — Erythroferrone appeared to function as a negative regulator of osteoblast and osteoclast activity, and its loss can result in decreased bone mineral density in beta-thalassemia, according to results of a study presented during the plenary session of ASH Annual Meeting and Exposition. The findings may provide new insights into the interaction between regulation of iron metabolism